Literature DB >> 27778436

Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison.

L Lafferty1, C Treloar2, J Guthrie3, G M Chambers4, T Butler1.   

Abstract

Prisoner populations are characterized by high rates of hepatitis C (HCV), up to thirty times that of the general population in Australia. Within Australian prisons, less than 1% of eligible inmates access treatment. Public health strategies informed by social capital could be important in addressing this inequality in access to HCV treatment. Twenty-eight male inmates participated in qualitative interviews across three correctional centres in New South Wales, Australia. All participants had recently tested as HCV RNA positive or were receiving HCV treatment. Analysis was conducted with participants including men with experiences of HCV treatment (n=10) (including those currently accessing treatment and those with a history of treatment) and those who were treatment naïve (n=18). Social capital was a resourceful commodity for inmates considering and undergoing treatment while in custody. Inmates were a valuable resource for information regarding HCV treatment, including personal accounts and reassurance (bonding social capital), while nurses a resource for the provision of information and care (linking social capital). Although linking social capital between inmates and nurses appeared influential in HCV treatment access, there remained opportunities for increasing linking social capital within the prison setting (such as nurse-led engagement within the prisons). Bonding and linking social capital can be valuable resources in promoting HCV treatment awareness, uptake and adherence. Peer-based programmes are likely to be influential in promoting HCV outcomes in the prison setting. Engagement in prisons, outside of the clinics, would enhance opportunities for linking social capital to influence HCV treatment outcomes.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  hepatitis C treatment; inmates; prisons; qualitative research; social capital

Mesh:

Year:  2016        PMID: 27778436     DOI: 10.1111/jvh.12627

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  5 in total

1.  Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.

Authors:  Nadine Kronfli; Roy Nitulescu; Joseph Cox; Erica Em Moodie; Alexander Wong; Curtis Cooper; John Gill; Sharon Walmsley; Valérie Martel-Laferrière; Mark W Hull; Marina B Klein
Journal:  J Int AIDS Soc       Date:  2018-11       Impact factor: 5.396

2.  Hepatitis C virus screening and treatment in Irish prisons from nurse managers' perspectives - a qualitative exploration.

Authors:  D Crowley; M C Van Hout; C Murphy; E Kelly; J S Lambert; W Cullen
Journal:  BMC Nurs       Date:  2019-06-13

3.  Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.

Authors:  Desmond Crowley; Ross Murtagh; Walter Cullen; Mary Keevans; Eamon Laird; Tina McHugh; Susan McKiernan; Sarah Jayne Miggin; Eileen O'Connor; Deirdre O'Reilly; Graham Betts-Symonds; Ciara Tobin; Marie Claire Van Hout; John S Lambert
Journal:  Harm Reduct J       Date:  2019-07-05

Review 4.  Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy.

Authors:  Thomas G Cotter; Donald M Jensen
Journal:  Drug Des Devel Ther       Date:  2019-07-29       Impact factor: 4.162

5.  Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.

Authors:  Rob Bielen; Samya R Stumo; Rachel Halford; Klára Werling; Tatjana Reic; Heino Stöver; Geert Robaeys; Jeffrey V Lazarus
Journal:  Harm Reduct J       Date:  2018-05-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.